← Eichor
Study identifier: NCT07536477 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

High-flow Nasal Cannula Oxygen Therapy Versus Conventional Oxygen Therapy in High-altitude Pulmonary Edema

Condition: High-altitude Pulmonary Edema  ·  Sponsor: Third Military Medical University

PhaseNA
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study aims to evaluate whether High-flow Nasal Cannula Oxygen Therapy (HFNC) provides superior respiratory support compared to Conventional Oxygen Therapy (COT) in patients with High-Altitude Pulmonary Edema (HAPE).

This description comes directly from the study's public registry record.

Talk to the study team

Yiding Li, Dr.  ·  +86 13101377031  ·  fygan@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

NO.953 HospitalXigazê, Tibet, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07536477